Drug-induced "Suspended Animation": Can a dream become true?

Critical Care Medicine

Volumn 43, Issue 7, 2015, Pages 1528-1530

  Asfar, Pierre ^a   Radermacher, Peter ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

cytochrome c oxidase; gaseous mediators; hypothermia; ischemia reperfusion injury; selenium; suspended animation

Indexed keywords

SELENIDE; SELENIUM;

CONTROLLED CLINICAL TRIAL (TOPIC); CORONARY ARTERY OCCLUSION; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTHERMIA; INDUCED HYPOTHERMIA; META ANALYSIS (TOPIC); METABOLIC INHIBITION; METABOLISM; NONHUMAN; PRIORITY JOURNAL; SUSPENDED ANIMATION; ANIMALS; MALE; MYOCARDIAL REPERFUSION INJURY;

ANIMALS; MALE; MYOCARDIAL REPERFUSION INJURY; SELENIUM;

EID: 84937597703     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000985     Document Type: Editorial

References (20)

1. Roth MB, Nystul T. Buying time in suspended animation. Sci Am 2005; 292:48-55
2. Singer M, De Santis V, Vitale D, et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364:545-548
3. Zobel C, Adler C, Kranz A, et al. Mild therapeutic hypothermia in cardiogenic shock syndrome. Crit Care Med 2012; 40:1715-1723
4. Bellamy R, Safar P, Tisherman SA, et al. Suspended animation for delayed resuscitation. Crit Care Med 1996; 24:S24-S47
5. Blackstone E, Morrison M, Roth MB. H2S induces a suspended animation-like state in mice. Science 2005; 308:518
6. Asfar P, Calzia E, Radermacher P. Is pharmacological, H2S-induced 'suspended animation' feasible in the ICU? Crit Care 2014; 18:215
7. Iwata A, Morrison ML, Blackwood JE, et al. Selenide Targets to Reperfusing Tissue and Protects It From Injury. Crit Care Med 2015; 43:1361-1367
8. McConnell KP, Dallam RD. Time-distribution examination of the in vivo incorporation of selenium into cytochrome c of the rat and its turnover. Nature 1962; 193:746-748
9. Mehta SL, Kumari S, Mendelev N, et al. Selenium preserves mitochondrial function, stimulates mitochondrial biogenesis, and reduces infarct volume after focal cerebral ischemia. BMC Neurosci 2012; 13:79
10. Elrod JW, Calvert JW, Morrison J, et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 2007; 104:15560-15565
11. Snijder PM, de Boer RA, Bos EM, et al. Gaseous hydrogen sulfide protects against myocardial ischemia-reperfusion injury in mice partially independent from hypometabolism. PLoS One 2013; 8:e63291
12. Halliwell B. The antioxidant paradox. Lancet 2000; 355:1179-1180
13. Stoppe C, Schalte G, Rossaint R, et al. The intraoperative decrease of selenium is associated with the postoperative development of multiorgan dysfunction in cardiac surgical patients. Crit Care Med 2011; 39:1879-1885
14. Alhazzani W, Jacobi J, Sindi A, et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-Analysis of randomized controlled trials. Crit Care Med 2013; 41:1555-1564
15. Sakr Y, Maia VP, Santos C, et al. Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis. Crit Care 2014; 18:R68
16. Berger MM, Chiolero RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007; 35:S584-S590
17. Forceville X. The effect of selenium therapy on mortality in patients with sepsis syndrome: simple selenium supplementation or real (5 H2O)Na2SeO3 pharmacological effect? Crit Care Med 2013; 41:1591-1592
18. Radermacher P, Haouzi P. A mouse is not a rat is not a man: species-specific metabolic responses to sepsis-A nail in the coffin of murine models for critical care research? Intensive Care Med Exp 2013; 1:7
19. Baumgart K, Wagner F, Gröger M, et al. Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice. Crit Care Med 2010; 38:588-595
20. Petrosillo G, Di Venosa N, Moro N, et al. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release. Free Radic Biol Med 2011; 50:477-483